Vikas S. Gupta MD , Kylie I. Holden MD, MS , Priscilla P. Chiu MD, PhD , Akila B. Ramaraj MD , Chase M. Miller MD , Elizabeth C. Popp MD , Noor Bakir MD , Rebecca A. Stark MD , Terry L. Buchmiller MD , Ashley H. Ebanks NP , Kevin P. Lally MD , Matthew T. Harting MD, MS , Congenital Diaphragmatic Hernia Study Group
{"title":"Recurrence in congenital diaphragmatic hernia: A multicenter, postdischarge pilot study","authors":"Vikas S. Gupta MD , Kylie I. Holden MD, MS , Priscilla P. Chiu MD, PhD , Akila B. Ramaraj MD , Chase M. Miller MD , Elizabeth C. Popp MD , Noor Bakir MD , Rebecca A. Stark MD , Terry L. Buchmiller MD , Ashley H. Ebanks NP , Kevin P. Lally MD , Matthew T. Harting MD, MS , Congenital Diaphragmatic Hernia Study Group","doi":"10.1016/j.surg.2025.109209","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The Congenital Diaphragmatic Hernia Study Group has previously identified factors associated with early hernia recurrence, but multicenter data on postdischarge outcomes were lacking. The purpose of this study is to assess diaphragmatic hernia recurrence rates in the first 5 years of life using a multicenter cohort.</div></div><div><h3>Methods</h3><div>A database was established with data from 4 centers collected retrospectively at perinatal, discharge, 2 years, and 5 years. The study included patients with congenital diaphragmatic hernia managed in the outpatient setting between 2010 and 2021. The primary outcome was recurrence of congenital diaphragmatic hernia requiring operative correction.</div></div><div><h3>Results</h3><div>Of the 472 infants with congenital diaphragmatic hernia identified, 297 (81%) had long-term follow-up data: 241 patients were followed up at 2 years and 113 at 5 years. Recurrence occurred in 35 (12%) patients, with higher rates in high-risk (17%) versus low-risk (8%) patients. Extracorporeal life support was associated with increased recurrence (23% vs 10%, predicted to be 32.0% vs 5.8%), and minimally invasive surgery repair had a higher recurrence rate (35% vs 7% for open repair, predicted to be 26.0% vs 6.3%). No difference in recurrence rates was found between patch and primary repair. The model predicted 5-year recurrence rates, higher than the observed rates, of 11.6%, 9.5%, 27.3%, and 33.0% for Congenital Diaphragmatic Hernia Study Group A–D stages, respectively.</div></div><div><h3>Conclusion</h3><div>Congenital diaphragmatic hernia defect size, extracorporeal life support, and minimally invasive surgery repair were associated with postdischarge recurrence. Smaller defects tend to recur earlier, whereas larger defects have a steady recurrence rate over 5 years. These findings should guide patient counseling and follow-up planning.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"181 ","pages":"Article 109209"},"PeriodicalIF":2.7000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0039606025000613","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/19 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The Congenital Diaphragmatic Hernia Study Group has previously identified factors associated with early hernia recurrence, but multicenter data on postdischarge outcomes were lacking. The purpose of this study is to assess diaphragmatic hernia recurrence rates in the first 5 years of life using a multicenter cohort.
Methods
A database was established with data from 4 centers collected retrospectively at perinatal, discharge, 2 years, and 5 years. The study included patients with congenital diaphragmatic hernia managed in the outpatient setting between 2010 and 2021. The primary outcome was recurrence of congenital diaphragmatic hernia requiring operative correction.
Results
Of the 472 infants with congenital diaphragmatic hernia identified, 297 (81%) had long-term follow-up data: 241 patients were followed up at 2 years and 113 at 5 years. Recurrence occurred in 35 (12%) patients, with higher rates in high-risk (17%) versus low-risk (8%) patients. Extracorporeal life support was associated with increased recurrence (23% vs 10%, predicted to be 32.0% vs 5.8%), and minimally invasive surgery repair had a higher recurrence rate (35% vs 7% for open repair, predicted to be 26.0% vs 6.3%). No difference in recurrence rates was found between patch and primary repair. The model predicted 5-year recurrence rates, higher than the observed rates, of 11.6%, 9.5%, 27.3%, and 33.0% for Congenital Diaphragmatic Hernia Study Group A–D stages, respectively.
Conclusion
Congenital diaphragmatic hernia defect size, extracorporeal life support, and minimally invasive surgery repair were associated with postdischarge recurrence. Smaller defects tend to recur earlier, whereas larger defects have a steady recurrence rate over 5 years. These findings should guide patient counseling and follow-up planning.
背景先天性膈疝研究小组先前已经确定了与早期疝复发相关的因素,但缺乏出院后结局的多中心数据。本研究的目的是通过多中心队列评估膈疝在生命前5年的复发率。方法回顾性收集围产期、产后、产后2年、产后5年4个中心的资料,建立数据库。该研究包括2010年至2021年间在门诊治疗的先天性膈疝患者。主要结果为需要手术矫正的先天性膈疝复发。结果在确诊的472例先天性膈疝患儿中,297例(81%)有长期随访数据:241例随访2年,113例随访5年。35例(12%)患者出现复发率,高危患者(17%)高于低危患者(8%)。体外生命支持与复发率增加相关(23% vs 10%,预测为32.0% vs 5.8%),微创手术修复具有更高的复发率(35% vs 7%,预测为26.0% vs 6.3%)。补片修复与初次修复的复发率无差异。该模型预测先天性膈疝研究组A-D期的5年复发率分别为11.6%、9.5%、27.3%和33.0%,高于观察到的复发率。结论先天性膈疝缺损大小、体外生命支持和微创手术修复与出院后复发有关。较小的缺陷往往复发较早,而较大的缺陷有稳定的复发率超过5年。这些发现应该指导患者咨询和随访计划。
期刊介绍:
For 66 years, Surgery has published practical, authoritative information about procedures, clinical advances, and major trends shaping general surgery. Each issue features original scientific contributions and clinical reports. Peer-reviewed articles cover topics in oncology, trauma, gastrointestinal, vascular, and transplantation surgery. The journal also publishes papers from the meetings of its sponsoring societies, the Society of University Surgeons, the Central Surgical Association, and the American Association of Endocrine Surgeons.